Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration.

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Abstract Text:

OBJECTIVES: Many AS patients report periods of perceived higher disease activity (flares). This pilot study aims to document disease activity patterns reported by AS patients and examine associations with disease-specific health status measures. METHODS: Consecutive AS patients (n = 114) were asked whether they experience flares, and if they experience symptoms of AS between flares. They were shown the Flare Illustration of disease patterns over time and asked to select the pattern that best described their disease (i) since symptom onset and (ii) in the past year. Associations between reported disease pattern and disease activity (Bath AS Disease Activity Index, BASDAI); functional impairment (Bath AS Functional Index, BASFI); AS Quality of Life (ASQoL); Back Pain (Nocturnal and Overall) and demographic features were assessed in a subsample (n = 83) (statistical significance defined at P 70% of patients) and patterns with constant symptoms since onset (vs intermittent symptoms) were associated with worse health status (ASQoL: P = 0.007; BASDAI: P = 0.029; BASFI: P = 0.013, overall back pain: P = 0.025). CONCLUSIONS: Almost all AS patients report flares in disease activity: 70-80% report constant symptoms with single/repeated flares, while 20-30% report flares with no intermittent symptoms. The former is associated with a significantly poorer health status. These findings will be validated in a prospective study.

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Rheumatology (Oxford, England)

VOLUME: 47

Page Numbers: 1213-8

Journal Abbreviation: Rheumatology (Oxford)

ISSN: 1462-0332

DAY: 6

MONTH: 06

YEAR: 2008

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100883501

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration.

AFFILIATION: Royal National Hospital for Rheumatic Diseases NHS Foundation Trust, Upper Borough Walls, Bath BA1 1RL, UK. m.stone@bath.ac.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Rheumatology (Oxford)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration Related Publications

• Abrupt Slowing of the Cerebral Circulation.
• Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population.
• Assessment of the impact of flares in ankylosing spondylitis disease activity using the Flare Illustration.
• Body weight and weight loss: are health messages reaching their target?
• Cell-mediated lympholysis of N-(3-nitro-4-hydroxy-5-iodophenylacetyl)-beta-anaylglycylglycyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by the H-2K and H-2D serological regions of the murine m
• Cerebral MR imaging in intravascular lymphomatosis.
• Clinical observations on morbid periodicity.
• DISCUSSION OF THE PATHOLOGICAL DIVISION OF ST. LUKE'S HOSPITAL CLINICAL CLUB.
• Editorial comment.
• Emotional factors in eye disease.
• Environmental Allergens: With Special Reference to Their Importance and Specificity.
• Ewing's tumor.
• Fatal agranulocytosis attributed to co-trimoxazole therapy.
• MILD MENTAL DISTURBANCES-PREVALENT CAUSES.
• NEUROLOGICAL FINDINGS IN ONE THOUSAND GROUP STUDY CASES.
• NOTES ON PATHOLOGICAL REFLEXES.
• NOTES ON SYPHILIS OF THE CENTRAL NERVOUS SYSTEM.
• Nerve Injuries: Their Influence on the Period of Disability.
• Oral contraceptives and death from myocardial infarction.
• Oral contraceptives and fatal subarachnoid haemorrhage.
• Retinol (vitamin A) and retinol-binding protein levels are decreased in ankylosing spondylitis: clinical and genetic analysis.
• Routine Examination of the Cerebrospinal Fluid in Suspected Syphilis of the Nervous System.
• SOME COMPARISONS BETWEEN WAR NEUROSES AND THOSE OF CIVIL LIFE.
• Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.
• Symptomatic acute reactive arthritis after an outbreak of salmonella.
• THE NEUROLOGICAL ASPECTS AND LATE SYMPTOMS OF EPIDEMIC ENCEPHALITIS.
• THE NEUROLOGICAL ASPECTS OF VISCEROPTOSIS.
• Teratogenesis and lymphocyte stimulation.
• The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project.
• Volume of liquor amnii in normal and abnormal pregnancy.